Catherine T. Doherty - Feb 24, 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Catherine T. Doherty
Stock symbol
DGX
Transactions as of
Feb 24, 2022
Transactions value $
-$347,215
Form type
4
Date filed
2/28/2022, 06:50 PM
Previous filing
Feb 25, 2022
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Sale -$347K -2.75K -4.1% $126.26 64.4K Feb 24, 2022 Direct F1
transaction DGX Common Stock Award $0 +3.33K +5.17% $0.00 67.7K Feb 24, 2022 Direct F2
holding DGX Common Stock 4.17K Feb 24, 2022 401(k)/SDCP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Award $0 +16.2K $0.00 16.2K Feb 24, 2022 Common Stock 16.2K $127.73 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.
F2 Represents an award of restricted share units.
F3 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
F4 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.